Brief: HLS Announces That Vascepa Is Now Reimbursed By British Columbia's Provincial Drug Plan
06/02/2024 11:32
Feb 6 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS ANNOUNCES THAT VASCEPA® IS NOW REIMBURSED BY BRITISH
COLUMBIA'S PROVINCIAL DRUG PLAN
* HLS THERAPEUTICS INC - PLA WITH BC PHARMACARE IS EFFECTIVE
FEBRUARY 6, 2024
Source text for Eikon: ID:nCNWBc914a
Further company coverage: HLS.TO
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease